Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. Our investigational products are designed to safely replace a patient’s diseased blood and immune system with a healthy one, delivering better outcomes with fewer risks than the standard of care. Our manufacturing platform uses single-cell precision to create proprietary, uniquely-defined products that have the potential to revolutionize allogeneic cell therapy. Our team of leading scientists, engineers and clinicians is united in our mission to transform the lives of patients. Together, we are working to deliver the promise of a cure, without the compromise. Please note, a member of the Orca Bio team will only ever communicate using an @orcabio.com email address.